Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Dec 2023
Leukemia

Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients

Autoren
Enssle JC et al.
Red-coloured rod-shaped bacteria in an electron micrograph.

© CDC/Alissa Eckert; James Archer

© CDC/Alissa Eckert; James Archer
May 16 2024

Prevention of tuberculosis: When should contact persons receive preventive treatment?

In a large-scale systematic review, researchers from an international consortium analysed more than 25,000 publications from the last 20 years. They examined the circumstances under which contact

Blue banner of the AMR Multi-Stakeholder Partnership Platform in the bottom part of the image; abstract depictions of microbes and drug capsules in red, blue, grey and white

© AMR Multi-Stakeholder Partnership Platform

© AMR Multi-Stakeholder Partnership Platform
May 14 2024

Call for actionable steps in response to the rising threat of antimicrobial resistance (AMR)

Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to the World Health Organisation (WHO), an estimated 4.95 million deaths were associated with

Nov 2023
Vaccines

The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium

Autoren
Poulimeneas D et al.
Oct 2023
Front Cell Infect Microbiol

The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice

Autoren
Do KTH et al.
Oct 2023
Open Forum Infect Dis

Primary Series and Booster Coronavirus Disease 2019 Vaccine Effectiveness in a Cohort of Healthcare Workers in Albania During a BA.1 and BA.2 Variant Period, January-May 2022

Autoren
Finci I et al.
Sep 2023
Eur J Pharm Biopharm

Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice

Autoren
Barbey C et al.
Oct 2023
Influenza Other Respir Viruses

The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May-November 2021

Autoren
Katz MA et al.
From left to right: Prof. Luka Cicin-Sain, Head of the "Viral Immunology" Department at the HZI; Adhara Madhuri, PhD student at the HZI; Henrik Klimke, Chairman of the Günter Hansmeier Krebsstiftung.

© HZI/Schwenner

© HZI/Schwenner
Apr 15 2024

Doctoral project researches immunotherapy of CMV infections in children with leukaemia

Leukaemia is the most common cancer in children. Cancer treatment severely weakens the children's immune system and they can easily develop opportunistic infections. One of the most common causes of

The cartoon illustration shows a semi-circular arc of medication capsules in different colours on a blue background and a lung with eyes, a smiling mouth and the words "YES! We can endTB" and "End TB" in a coloured circle.

© WHO

© WHO
Mar 21 2024

World Tuberculosis Day on 24 March 2024 under the motto "Yes! We can end TB!"

While tuberculosis (TB) has become relatively rare in Germany and other industrialised nations, around ten million people contract the bacterial infection every year, especially in resource-poorer

Pagination

Previous page ‹‹
Seite 5 Seite 6 Seite 7 Seite 8 Current page 9 Seite 10 Seite 11 Seite 12 Seite 13
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states